Sheppard Mullin's Health-e Law Sheppard Mullin, with Phil Kim and Sara Shanti

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. In this episode, Sheppard Mullin partners Carolyn Metnick and Michael Orlando join Phil Kim to discuss the firm’s experience at HIMSS Global Health Conference 2024 in Orlando. The conference is one of the leading health IT educational gatherings and draws visionary CIOs, top-level executives, dedicated healthcare providers, and health IT professionals to cover the latest trends in digital health, including AI and cybersecurity.  
 
What We Discussed in this Episode:
Were there any noticeable shifts in vendors from HIMSS 2024?
What sort of role did AI play in this year's conference?
How were conversations around AI different this year versus last year?
How can AI help with healthcare equity and patient disparities?
What was the discussion around cybersecurity?
How can ocular imaging technology change the business model for healthcare delivery and patient care?



About Carolyn Metnick
Carolyn Metnick is a partner in Sheppard Mullin’s Corporate Practice Group in the firm's Chicago office and a member of the Healthcare and Privacy & Cybersecurity Teams.
Carolyn represents a range of healthcare industry clients, including hospitals and health systems, physician organizations and digital health companies. She advises on healthcare regulatory and transactional matters, focusing on health information privacy and security. 
Carolyn advises clients on a range of privacy and security laws, including HIPAA and the California Consumer Privacy Act (CCPA). She also counsels businesses in data breach investigations and compliance with federal and state breach notification laws. Carolyn is a Certified Information Privacy Professional/United States (CIPP/US) and a Certified Information Privacy Professional/Europe (CIPP/E). 
Carolyn also represents healthcare industry clients in transactional matters, guiding clients through joint ventures, mergers and acquisitions, and advising on healthcare regulatory issues. Her background as a former litigator helps inform her transactional work. 
 
About Michael Orlando
Michael Orlando is a corporate and intellectual property transactions partner in the firm's San Diego (Del Mar) office. He is Co-Team Leader of the firm's Technology Transactions Team, and a member of the Life Sciences and Digital Health teams. He founded a software-as-a-service (SaaS) business prior to attending law school, and worked at a publicly-traded biotechnology company on an in-house secondment, and uses that experience in bringing a practical, business-oriented approach to his engagements. 
For over 20 years he has been assisting innovators, cutting-edge technology companies and other organizations develop, acquire, sell, and commercialize intellectual property assets, including technology licensing, commercial agreements, strategic partnerships, research, development and collaboration contracts, manufacturing and supply arrangements, outsourcing, and corporate transactions.

 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the bu

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team, alongside brilliant experts and thought leaders, share how innovations can solve some of healthcare’s (and maybe the world’s) biggest problems if properly navigated. 
In this special episode, partners Sara Shanti and Caroline Metnick join Phil Kim to discuss Sheppard Mullin’s recent attendance at ViVE 2024, the premier conference for digital health innovators primarily focusing on optimizing patient care and improving the patient user experience.
 
What We Discussed in this Episode:
What were some notable takeaways from ViVE 2024?
How is AI poised to improve healthcare delivery?
How might virtual care models help reduce burnout among clinicians and improve access to care?
How were the perils of AI addressed, particularly its potential to perpetuate healthcare bias? Including automating bias.
Why is ethical AI governance critical in healthcare?
How is data driving both opportunity and risk in the healthcare sector?
How stakeholders struggle with data fragmentation and data as a valued asset. 
 
About Carolyn Metnick
Carolyn Metnick is a partner in Sheppard Mullin’s Corporate Practice Group in the firm's Chicago office and a member of the Healthcare and Privacy & Cybersecurity Teams.
Carolyn represents a range of healthcare industry clients, including hospitals and health systems, physician organizations and digital health companies. She advises on healthcare regulatory and transactional matters, focusing on health information privacy and security. 
Carolyn advises clients on a range of privacy and security laws, including HIPAA and the California Consumer Privacy Act (CCPA). She also counsels businesses in data breach investigations and compliance with federal and state breach notification laws. Carolyn is a Certified Information Privacy Professional/United States (CIPP/US) and a Certified Information Privacy Professional/Europe (CIPP/E). 
Carolyn also represents healthcare industry clients in transactional matters, guiding clients through joint ventures, mergers and acquisitions, and advising on healthcare regulatory issues. Her background as a former litigator helps inform her transactional work. 
 
About Sara Shanti
A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth.
At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.
 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various heal

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team, alongside brilliant experts and thought leaders, share how innovations can solve some of healthcare’s (and maybe the world’s) biggest problems if properly navigated. In this episode, Deirdre O’Neill of Hertility Health joins us to discuss the growing role of DiagnosTech in fertility and reproductive health.
 
What We Discussed in This Episode:
What challenges and opportunities do you see on the horizon?
What positive trends have emerged due to the changes we’ve witnessed in this millennium?
Can you discuss some of the amazing collaborations Hertility Health is engaged in?
How might Hertility’s mission be impacted by technology and other industry players moving into the space?
Can you explain the concept of DiagnosTech?
 
About Deirdre O’Neill
Deirdre O’Neill is the Chief Commercial & Legal Officer at Hertility Health, a women’s healthcare startup offering unique diagnostic testing that provides advanced, data-driven insights into reproductive health, fertility decline and the onset of menopause. A dual-qualified lawyer in England and Ireland, Deirdra holds a Master's Degree in Medical Law from King’s College London. After working in Venture Capital Law, she decided to enter the world of startups full-time and subsequently co-founded Hertility, where she currently oversees corporate strategy and deals with legal, scaling, and business operations.
 
About Sara Shanti
A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth.
At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.
 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil regularly advises clients on matters related to healthcare compliance, including liability exposure, the Stark law, anti-kickback statutes, and HIPAA/HITECH privacy issues. He also provides counsel on state and federal laws, business structuring formation, employment issues, and involving government agencies, including state and federal agencies.
 
Contact Info:
Deirdre O’Neill 
Sa

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team, alongside brilliant experts and thought leaders, share how innovations can solve some of healthcare’s (and maybe the world’s) biggest problems, if properly navigated. In this episode, Craig Lund, co-founder and CEO of Mightier, joins us to discuss the role of gamification in healthcare, including its potential to improve both access to care and patient engagement.
 
What We Discussed in This Episode:
What is gamification in healthcare?
What solutions does gamification offer that the healthcare industry would otherwise struggle to provide?
How can gamification improve access to mental and behavioral health services?
How might gamification help overcome some of the stigma that often prevents kids and their families from engaging with mental health services?
How do you see gamification growing across the broader healthcare industry?
What must be done to ensure healthcare consumers can access these solutions and to ensure they are affordable?
What are you most excited about for the future?
 
About Craig Lund
Craig Lund is co-founder and CEO of Mightier, an innovative bio-responsive platform that helps children develop emotional calming and coping skills through fun video game play. 
Before co-founding the company in 2016, Craig served as interim CEO of Selux Diagnostics, a company transforming antibiotic medicine, and the Chief Commercial Officer of 1366 Technologies, a solar company out of MIT. From 2004 to 2006, he worked for the US Department of Defense in Iraq to launch the government securities market and for Endeavor Argentina, where he helped entrepreneurs start new businesses. He is a graduate of Dartmouth College and Harvard Business School.
 
About Sara Shanti
A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth.
At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.
 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil regularly advises clients on matters related to healthcare compliance, including liability ex

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team, alongside brilliant experts and thought leaders, share how innovations can solve some of healthcare’s (and maybe the world’s) biggest problems, if properly navigated. In this episode, Sheppard Mullin healthcare team leader Eric Klein joins us to discuss the future of health tech and what we can expect to see in 2024.
 
What We Discussed in this Episode:
Where is healthcare disruption expected in 2024 and how will that impact costs?
Where is digital health headed in 2024? Where will it have the most significant impact?
What are savvy investors looking for in 2024?
How can industry players make themselves more attractive to investors?
What should providers, payers, and industry stakeholders consider as they look to make tech investments?
How will the expected wave of consolidation impact the digital health space?
 
About Eric Klein
With over 35 years of practical legal and business experience, Eric Klein is widely acknowledged as one of the most experienced attorneys in population health management, physician alignment, and global risk transactions. As a partner in Sheppard Mullin’s Century City Office, he leads the firm’s distinguished national healthcare practice, which has been honored as a Law360 U.S. Health Care Practice Group of the Year three times in the past seven years.
Over the last decade, Eric has advised on over 85 hospital mergers, acquisitions, and joint ventures, more than 85 health plan mergers and acquisitions, and many of the country’s largest physician services transactions, establishing him as one of the nation’s most active physician group, health plan and hospital M&A and joint venture lawyers.
 
About Sara Shanti
A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth.
At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.
 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil regularly advises clients on matters related to healthcare compliance, including liability exposure, the Stark law, anti

Welcome to Health-e Law, Sheppard Mullin's podcast addressing the fascinating health-tech topics and trends of the day. Our digital health legal team, alongside brilliant experts and thought leaders, share how innovations can solve some of healthcare’s (and maybe the world’s) biggest problems, if properly navigated. In this episode, Viveka Rydell-Anderson, CEO of Pacific Vision Foundation, joins us to discuss the critical need for specialized care and how emerging digital technologies can help overcome access challenges.
 
What We Discussed In This Episode
What specifically is specialized care?
How is new and emerging technology transforming specialized care?
Where are we today in terms of access?
How can the industry transition from “sick care” to “healthcare”? 
Do you see patients embracing this technology?
What do developers need to consider as they seek to meet patients' needs?
What are you hearing from providers? What do they want from technology?
What technologies, including in FemTech, do you see as poised to make a difference and mitigate stigmas?
From a lawyer's perspective, how do you see businesses having to adapt and navigate what's ahead of them?
 
About Viveka Rydell-Anderson
With over 20 years of experience as a lawyer, healthcare executive and innovator, Viveka Rydell-Anderson is a passionate trailblazer in the realm of healthcare equity and access.
Viveka is the CEO of Pacific Vision Foundation and the president of the HIMSS Northern California Chapter. She has deep experience in FemTech and specialized care spaces, among her many other impressive achievements, including holding a Master of Science in Clinical Informatics Management from Stanford University School of Medicine in addition to her law degree from UC Berkeley.
Before taking on her current role, Viveka spent 14 years as CEO of PDI Surgery Center, a nonprofit Ambulatory Surgery Center providing specialty dental care to children and special needs patients in 30+ California counties. She then co-founded two MedTech startups: ImageChain.ai and Mamsen Health. 
 
About Sara Shanti
A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth.
At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.
 
About Phil Kim
A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies.
Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and s